GO:0043028 cysteine-type endopeptidase regulator activity involved in apoptotic process: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043028 describes a molecular function in which a protein binds to and modulates the activity of a cysteine-type endopeptidase (caspase) that operates in apoptosis.
• This regulator activity is essential for controlling caspase activation, ensuring that apoptotic cell death is triggered only when appropriate.
• Dysregulation of cysteine-type endopeptidase regulators is linked to cancer, neurodegeneration, and inflammatory diseases.
• Key regulators include BCL-2 family proteins, IAPs, and FLIP, which directly or indirectly influence caspase activity.
• Experimental models such as CRISPR knockout, point mutation, and overexpression are used to dissect the precise role of these regulators in apoptosis.
• Bioinformatics and network pharmacology approaches have identified cysteine-type endopeptidase regulators as biomarkers and therapeutic targets in multiple cancers.
Description
The Gene Ontology (GO) term GO:0043028, cysteine-type endopeptidase regulator activity involved in apoptotic process, defines a molecular function where a protein binds to and modulates the activity of a cysteine-type endopeptidase (caspase) that participates in apoptosis. This activity is central to the precise control of programmed cell death, a process critical for development, tissue homeostasis, and immune defense. Caspases are synthesized as inactive zymogens and require tightly regulated activation; regulators of this activity ensure that caspases are activated only in response to specific signals, preventing accidental cell death. Research into GO:0043028 has revealed a complex network of pro- and anti-apoptotic regulators. For example, BCL-2 family proteins such as BAX and BAK promote caspase activation, while BCL-2 and BCL-xL inhibit it. Inhibitor of apoptosis proteins (IAPs) directly bind and inhibit caspases, and their activity is antagonized by SMAC/DIABLO. Understanding these regulatory mechanisms is essential for developing therapies that can selectively induce apoptosis in cancer cells or prevent it in neurodegenerative conditions. Recent studies using bioinformatics and network pharmacology have highlighted the importance of cysteine-type endopeptidase regulators as diagnostic and prognostic biomarkers. For instance, in breast cancer, FKBP-related ncRNA-mRNA axes involving apoptotic regulators have been identified. In steroid-induced osteonecrosis of the femoral head, pyroptosis-related biomarkers, including caspase regulators, have been proposed. These findings underscore the broad relevance of GO:0043028 across human diseases.
cysteine-type endopeptidase regulator activity involved in apoptotic process At A Glance
| GO ID | GO:0043028 |
|---|---|
| GO term | cysteine-type endopeptidase regulator activity involved in apoptotic process |
| Ontology | molecular_function |
| Synonym | caspase regulator activity |
| Major function | Binds to and modulates the activity of a cysteine-type endopeptidase involved in apoptosis |
| Regulated entities | Caspases (e.g., CASP3, CASP7, CASP8, CASP9) |
| Direction of regulation | Both positive (agonism) and negative (antagonism) modulation |
| Associated processes | Apoptosis, pyroptosis, inflammation |
| Disease relevance | Cancer, neurodegeneration, autoimmune disorders |
What Is GO:0043028?
GO:0043028 is defined as the molecular function of binding to and modulating the activity of a cysteine-type endopeptidase (caspase) that is involved in the apoptotic process. This term encompasses proteins that either enhance (agonists) or suppress (antagonists) caspase activity, thereby controlling the initiation and execution of apoptosis. It is synonymous with caspase regulator activity.
Why Is cysteine-type endopeptidase regulator activity involved in apoptotic process Important in Cell Biology?
GO:0043028 is critically important because it governs the decision between cell survival and death. Caspases are the executioners of apoptosis, and their activity must be tightly regulated to avoid pathological outcomes. Regulators of cysteine-type endopeptidases are therefore key nodes in cancer biology, where evasion of apoptosis is a hallmark, and in neurodegenerative diseases, where excessive apoptosis contributes to neuronal loss. Targeting these regulators offers therapeutic opportunities, and their expression patterns serve as biomarkers for disease diagnosis and prognosis.
• Controls caspase activation, a decisive step in apoptosis.
• Dysregulation leads to cancer, as apoptotic evasion promotes tumor survival.
• Excessive caspase activity contributes to neurodegeneration.
• Regulators are targets for cancer therapy (e.g., IAP antagonists).
• Biomarkers for diagnosis and prognosis in multiple cancers.
• Involved in inflammatory diseases through pyroptosis regulation.
• Key to understanding chemotherapy resistance.
• Essential for normal development and tissue homeostasis.
• Modulated by non-coding RNAs, offering new therapeutic avenues.
• Studied using CRISPR screens to identify novel regulators.
What Happens During cysteine-type endopeptidase regulator activity involved in apoptotic process?
Initiation of Apoptosis
In simple terms: The cell receives a signal to die, and regulators get ready to activate caspases.
Apoptosis can be initiated through intrinsic (mitochondrial) or extrinsic (death receptor) pathways. In the intrinsic pathway, cellular stress leads to mitochondrial outer membrane permeabilization, releasing cytochrome c and SMAC/DIABLO. These factors promote caspase activation by neutralizing IAPs. In the extrinsic pathway, death ligands bind receptors, recruiting adaptor proteins and pro-caspase-8/10. Regulators such as FLIP modulate this step. Both pathways converge on executioner caspases (CASP3, CASP7).
Regulation of Caspase Activation
In simple terms: Regulators either help or block caspases from becoming active.
BCL-2 family proteins regulate mitochondrial permeabilization: BAX/BAK promote it, while BCL-2/BCL-xL inhibit it. IAPs (e.g., XIAP) directly bind and inhibit caspases-3, -7, and -9. SMAC/DIABLO antagonizes IAPs, freeing caspases. FLIP inhibits caspase-8 activation at the DISC. These regulators ensure that caspase activation is tightly controlled.
Execution of Apoptosis
In simple terms: Once caspases are active, they dismantle the cell.
Active executioner caspases cleave hundreds of substrates, leading to DNA fragmentation, membrane blebbing, and formation of apoptotic bodies. Regulators of cysteine-type endopeptidases influence the threshold and kinetics of this execution phase. For example, XIAP can inhibit active caspases, while SMAC release promotes execution.
Crosstalk with Other Cell Death Pathways
In simple terms: Apoptosis regulators also affect other death processes like pyroptosis.
Caspase-1 and caspase-11 (in mice) regulate pyroptosis, an inflammatory cell death. Regulators of these caspases, such as inflammasome components, are also covered by GO:0043028 when they modulate cysteine-type endopeptidases in apoptotic-like processes. This crosstalk is important in infection and inflammation.
Key Genes Involved in GO:0043028 cysteine-type endopeptidase regulator activity involved in apoptotic process
The following genes encode proteins that exhibit cysteine-type endopeptidase regulator activity involved in apoptotic process (GO:0043028) or directly modulate such regulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BCL2 | Anti-apoptotic; inhibits BAX/BAK, preventing caspase activation | Overexpressed in many cancers; target for inhibitors |
| BAX | Pro-apoptotic; promotes mitochondrial permeabilization and caspase activation | Mutated in cancers; used in KO studies |
| BAK | Pro-apoptotic; similar to BAX | Redundant with BAX; double KO blocks apoptosis |
| XIAP | Inhibits caspases-3, -7, -9 | Overexpressed in cancers; target for SMAC mimetics |
| SMAC/DIABLO | Antagonizes IAPs, promoting caspase activation | Pro-apoptotic; studied in cancer therapy |
| CASP8 | Initiator caspase in extrinsic pathway | Regulated by FLIP; mutations in immunodeficiency |
| CASP9 | Initiator caspase in intrinsic pathway | Activated by cytochrome c; regulated by BCL-2 family |
| CASP3 | Executioner caspase | Final effector; KO leads to defective apoptosis |
| CASP7 | Executioner caspase | Redundant with CASP3 |
| FLIP | Inhibits caspase-8 activation | Overexpressed in tumors; promotes survival |
| BCL2L1 (BCL-xL) | Anti-apoptotic; inhibits BAX/BAK | Target for cancer therapy |
| MCL1 | Anti-apoptotic; inhibits BAK | Amplified in cancers; resistance to chemotherapy |
| BID | Pro-apoptotic; links extrinsic and intrinsic pathways | Cleaved by caspase-8; activates BAX/BAK |
| PMAIP1 (NOXA) | Pro-apoptotic; inhibits MCL1 | Regulated by p53; involved in chemosensitivity |
| BBC3 (PUMA) | Pro-apoptotic; inhibits BCL-2 family | p53 target; essential for apoptosis |
| CASP1 | Inflammatory caspase; involved in pyroptosis | Regulated by inflammasomes; relevant to infection |
| CASP4 | Inflammatory caspase in humans | Similar to caspase-11; pyroptosis |
| CASP5 | Inflammatory caspase | Less studied; potential regulator |
How Is cysteine-type endopeptidase regulator activity involved in apoptotic process Regulated?
The activity of cysteine-type endopeptidase regulators is controlled at multiple levels. Transcriptionally, p53 induces pro-apoptotic regulators such as PUMA and NOXA. Post-translationally, phosphorylation of BCL-2 family proteins modulates their function; for example, JNK phosphorylates BCL-2 to inhibit it. Non-coding RNAs, including microRNAs, can target apoptotic regulators; for instance, miR-15a/16-1 represses BCL2. Additionally, ubiquitin-proteasome degradation controls the stability of IAPs and other regulators. These regulatory layers ensure that apoptosis is executed only under appropriate conditions.
cysteine-type endopeptidase regulator activity involved in apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCL2 | Follicular lymphoma; apoptosis evasion | Overexpression in lymphoma cell lines; KO in mice |
| XIAP | Cancer resistance; chemoresistance | KO in cancer cells; SMAC mimetic treatment |
| CASP8 | Immunodeficiency; ALPS-like | Point mutation knock-in in mice |
| CASP1 | Inflammatory diseases; sepsis | KO in macrophages; inflammasome activation |
| BAX | Cancer; neurodegeneration | KO mice; overexpression in neurons |
Cancer
Evasion of apoptosis is a hallmark of cancer. Overexpression of anti-apoptotic regulators such as BCL-2, BCL-xL, and XIAP is common in many malignancies, leading to resistance to chemotherapy and radiation. Conversely, loss of pro-apoptotic regulators like BAX or PUMA contributes to tumorigenesis. Targeting these regulators with small molecule inhibitors (e.g., venetoclax for BCL-2) has shown clinical success. Bioinformatics studies have identified cysteine-type endopeptidase regulators as prognostic biomarkers in breast cancer, glioblastoma, and leukemia.
Neurodegenerative Diseases
Excessive apoptosis contributes to neuronal loss in Alzheimer's, Parkinson's, and Huntington's diseases. Upregulation of pro-apoptotic regulators like BAX and caspases has been observed in affected brain regions. Inhibiting caspase activity or enhancing anti-apoptotic regulators is a potential therapeutic strategy. However, the role of specific regulators is complex and context-dependent.
Inflammatory and Infectious Diseases
Caspase-1 and caspase-11 regulate pyroptosis, an inflammatory cell death important for host defense. Regulators of these caspases, such as inflammasome sensors, are critical in sepsis and inflammatory disorders. Dysregulated pyroptosis contributes to tissue damage in conditions like steroid-induced osteonecrosis. Modulating these regulators could provide therapeutic benefits.
Autoimmune and Immunodeficiency Disorders
Defects in apoptosis regulators can cause autoimmune lymphoproliferative syndrome (ALPS) due to mutations in FAS or caspase-10, or immunodeficiency from caspase-8 deficiency. Proper regulation of cysteine-type endopeptidases is essential for immune homeostasis.
From cysteine-type endopeptidase regulator activity involved in apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate caspase-3 activation? | CRISPR knockout of gene X in HeLa cells, followed by apoptosis induction |
| Does mutation Y in BCL2 affect its anti-apoptotic function? | Point mutation knock-in in cancer cell lines |
| Can overexpression of XIAP protect against apoptosis? | Overexpression of XIAP in primary neurons |
| What is the role of caspase-8 in immune development? | Knock-in of caspase-8 point mutation in mice |
| How does SMAC mimetic affect IAP-caspase interaction? | Knockout of XIAP and treatment with SMAC mimetic |
| Does non-coding RNA regulate BCL2 expression? | Overexpression of miRNA in breast cancer cells |
How to Study the cysteine-type endopeptidase regulator activity involved in apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for apoptosis regulation | Identify novel regulators |
| RNA-seq | Transcriptomic changes | Discover pathways and biomarkers |
| Co-IP / mass spec | Protein-protein interactions | Map caspase-regulator complexes |
| Caspase activity assay | Enzymatic activity of caspases | Validate regulator function |
| Annexin V flow cytometry | Phosphatidylserine exposure | Quantify apoptosis |
| Western blot | Protein expression and cleavage | Detect caspase processing |
| FRET biosensor imaging | Real-time caspase activation | Live-cell dynamics |
| Network pharmacology | Drug-target interactions | Predict therapeutic candidates |
CRISPR-Cas9 Knockout Screening
Genome-wide CRISPR knockout screens can identify genes that regulate caspase activation and apoptosis. Cells are transduced with a lentiviral sgRNA library, selected, and treated with apoptotic stimuli. sgRNAs that confer resistance or sensitivity are enriched and sequenced. This approach has uncovered novel regulators of cysteine-type endopeptidase activity.
RNA Sequencing and Bioinformatics
RNA-seq of cells or tissues with altered apoptotic regulators can reveal downstream pathways. Differential expression analysis, GO enrichment, and network pharmacology identify key nodes. For example, FKBP-related ncRNA-mRNA axes in breast cancer were identified using bioinformatics. Similar approaches have been used in glioblastoma and retinoblastoma.
Proteomics and Interaction Studies
Co-immunoprecipitation and mass spectrometry can identify proteins that bind to caspases or their regulators. For instance, XIAP-caspase interactions are studied using recombinant proteins and pull-down assays. Proximity ligation assays can visualize interactions in situ.
Apoptosis Assays
Flow cytometry with Annexin V/PI staining, caspase activity assays (e.g., Caspase-Glo), and TUNEL staining measure apoptosis. These are used to validate the functional impact of regulator knockout or overexpression. Real-time imaging of caspase activation using FRET biosensors provides kinetic data.
How CRISPR Can Be Used to Study GO:0043028 cysteine-type endopeptidase regulator activity involved in apoptotic process
Knockout
CRISPR knockout of a candidate regulator gene (e.g., BCL2, XIAP) in cell lines or primary cells allows assessment of its role in apoptosis. For example, XIAP knockout sensitizes cancer cells to chemotherapy. Knockout of BAX and BAK blocks intrinsic apoptosis. These models are essential for validating gene function.
Point Mutation
Introducing specific point mutations (e.g., in the caspase-binding domain of XIAP or phosphorylation sites of BCL-2) using CRISPR base editing or HDR can dissect domain functions. For instance, mutation of the BIR domain of XIAP abolishes caspase inhibition. Such models provide mechanistic insights.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) of regulators enables live-cell imaging and proteomics. Knock-in of disease-associated mutations (e.g., caspase-8 mutations in immunodeficiency) recapitulates human phenotypes. These models are valuable for studying dynamics and interactions.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of anti-apoptotic regulators (e.g., BCL-2, BCL-xL) confers resistance to apoptosis, modeling cancer chemoresistance. Overexpression of pro-apoptotic regulators (e.g., BAX) induces cell death, useful for studying activation mechanisms.
How EDITGENE Supports cysteine-type endopeptidase regulator activity involved in apoptotic process Research
Researchers studying cysteine-type endopeptidase regulator activity involved in apoptotic process-related genes often need to determine whether a candidate gene is causally involved in apoptosis regulation, whether specific mutations alter its function, or whether its overexpression is sufficient to change cell fate. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for cysteine-type endopeptidase regulator activity involved in apoptotic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| BID Knockout HEK293 Cell Line | EDJ-KQ1746 | Human | 637 | Details Get a Quote |
| FOXL2 Knockout HEK293 Cell Line | EDJ-KQ2444 | Human | 668 | Details Get a Quote |
| FOXL2 Knockout A-549 Cell Line | EDJ-KQ22960 | Human | 668 | Details Get a Quote |
| FOXL2 Knockout HeLa Cell Line | EDJ-KQ22961 | Human | 668 | Details Get a Quote |
| BID Knockout A-549 Cell Line | EDJ-KQ21611 | Human | 637 | Details Get a Quote |
| BID Knockout HCT 116 Cell Line | EDJ-KQ21612 | Human | 637 | Details Get a Quote |
| BID Knockout HeLa Cell Line | EDJ-KQ21613 | Human | 637 | Details Get a Quote |
| FOXL2 Knockout HCT 116 Cell Line | EDJ-KQ69695 | Human | 668 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records
Frequently Asked Questions About cysteine-type endopeptidase regulator activity involved in apoptotic process
What is GO:0043028?
GO:0043028 is a Gene Ontology molecular function term that describes proteins which bind to and modulate the activity of cysteine-type endopeptidases (caspases) involved in apoptosis.
What genes are involved in cysteine-type endopeptidase regulator activity involved in apoptotic process?
Key genes include BCL2, BAX, BAK, XIAP, SMAC/DIABLO, CASP8, CASP9, CASP3, FLIP, and MCL1, among others.
How does cysteine-type endopeptidase regulator activity affect cancer?
Dysregulation of these regulators can lead to apoptosis evasion, a hallmark of cancer. Overexpression of anti-apoptotic regulators like BCL-2 and XIAP promotes tumor survival and chemoresistance.
What are the research methods to study caspase regulators?
Common methods include CRISPR knockout screens, RNA-seq, co-immunoprecipitation, caspase activity assays, and flow cytometry.
What diseases are associated with cysteine-type endopeptidase regulator activity?
Cancer, neurodegenerative diseases, inflammatory disorders, and autoimmune diseases are linked to dysregulated caspase regulators.
How can CRISPR be used to study GO:0043028?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of caspase regulators in apoptosis.
What is the synonym for GO:0043028?
The synonym is caspase regulator activity.
Which ontology does GO:0043028 belong to?
It belongs to the molecular_function ontology.
What is the role of BCL-2 in apoptosis?
BCL-2 is an anti-apoptotic regulator that inhibits BAX/BAK, preventing mitochondrial permeabilization and caspase activation.
How does XIAP regulate caspases?
XIAP directly binds and inhibits caspases-3, -7, and -9, blocking apoptosis. Its activity is antagonized by SMAC/DIABLO.
Conclusion
GO:0043028, cysteine-type endopeptidase regulator activity involved in apoptotic process, is a fundamental molecular function that controls the life-or-death decision of cells. Its regulators are critical in development, tissue homeostasis, and disease. Understanding their mechanisms offers therapeutic opportunities in cancer, neurodegeneration, and inflammation. Advanced CRISPR models and bioinformatics tools are indispensable for dissecting these pathways and translating findings into clinical applications.
References
- 1. Xiong H et al.. 2020. FKBP-related ncRNA-mRNA axis in breast cancer.. Genomics 112(6):4595-4607 PMID: 32814092
- 2. Chai JL et al.. 2023. Pyroptosis -related potential diagnostic biomarkers in steroid-induced osteonecrosis of the femoral head.. BMC Musculoskelet Disord 24(1):609 PMID: 37491198
- 3. Zhao XM et al.. 2021. Bioinformatics analysis of key biomarkers for retinoblastoma.. J Int Med Res 49(6):3000605211022210 PMID: 34187205
- 4. Guan S et al.. 2022. Bioinformatic identification of differentially expressed genes regulated by DNA-methylation in glioblastoma.. Eur J Neurosci 55(5):1278-1290 PMID: 34963193
- 5. Tan XY et al.. 2023. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].. Zhongguo Zhong Yao Za Zhi 48(18):5056-5067 PMID: 37802848
- 6. Zhang H et al.. 2021. Screening and identification of key genes in imatinib-resistant chronic myelogenous leukemia cells: a bioinformatics study.. Hematology 26(1):408-414 PMID: 34053416
- 7. Yu B et al.. 2021. Network pharmacology study on the mechanism of the Chinese medicine Radix Isatidis (Banlangen) for COVID-19.. Medicine (Baltimore) 100(32):e26881 PMID: 34397905
- 8. Zhao C et al.. 2023. The effect of acute toxicity from tributyltin on Liza haematocheila liver: Energy metabolic disturbance, oxidative stress, and apoptosis.. Aquat Toxicol 258:106506 PMID: 36989927
